Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Clinical trial NCT07594119 · RECRUITING
Trial details
- NCT number
- NCT07594119
- Sponsor
- Rapport Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2029-07-01
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.